You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Harvard Business School
McKesson
Colorcon
Mallinckrodt

Last Updated: April 14, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 209808

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

NDA 209808 describes CLOBAZAM, which is a drug marketed by Amneal, Bionpharma Inc, Hetero Labs Ltd Iii, Hikma, Lannett Co Inc, Lupin Ltd, Mylan, Taro, Teva Pharms Usa, Upsher Smith Labs, Vistapharm, Accord Hlthcare, Alkem Labs Ltd, Amneal Pharms Co, Apotex, Breckenridge, Celltrion, Micro Labs, Piramal Hlthcare Uk, and Zydus Pharms, and is included in twenty-seven NDAs. It is available from eighteen suppliers. Additional details are available on the CLOBAZAM profile page.

The generic ingredient in CLOBAZAM is clobazam. There are ten drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the clobazam profile page.
Summary for 209808
Tradename:CLOBAZAM
Applicant:Piramal Hlthcare Uk
Ingredient:clobazam
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 209808
Suppliers and Packaging for NDA: 209808
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOBAZAM clobazam TABLET;ORAL 209808 ANDA Sandoz Inc. 0781-8013 0781-8013-01 100 TABLET in 1 BOTTLE, PLASTIC (0781-8013-01)
CLOBAZAM clobazam TABLET;ORAL 209808 ANDA Sandoz Inc. 0781-8014 0781-8014-01 100 TABLET in 1 BOTTLE, PLASTIC (0781-8014-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Oct 22, 2018TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Oct 22, 2018TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
AstraZeneca
Mallinckrodt
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.